111 related articles for article (PubMed ID: 36758602)
1. [Clinical analysis of immune function and intestinal flora changes in patients with oral squamous carcinoma before and after treatment].
Qian Y; Deng C; Xu XB; Chen YJ; Hu YP; Hong LL; Feng DJ
Shanghai Kou Qiang Yi Xue; 2022 Oct; 31(5):523-529. PubMed ID: 36758602
[TBL] [Abstract][Full Text] [Related]
2. Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation.
Rai AK; Panda M; Das AK; Rahman T; Das R; Das K; Sarma A; Kataki AC; Chattopadhyay I
Arch Microbiol; 2021 Jan; 203(1):137-152. PubMed ID: 32783067
[TBL] [Abstract][Full Text] [Related]
3. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
Front Immunol; 2022; 13():922195. PubMed ID: 35935989
[TBL] [Abstract][Full Text] [Related]
4. Increased tumor-infiltrating plasmacytoid dendritic cells predicts poor prognosis in oral squamous cell carcinoma.
Han N; Zhang Z; Liu S; Ow A; Ruan M; Yang W; Zhang C
Arch Oral Biol; 2017 Jun; 78():129-134. PubMed ID: 28242507
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
[TBL] [Abstract][Full Text] [Related]
6. Hypovitaminosis D, oral potentially malignant disorders, and oral squamous cell carcinoma: a systematic review.
Maturana-Ramírez A; Aitken-Saavedra J; Guevara-Benítez AL; Espinoza-Santander I
Med Oral Patol Oral Cir Bucal; 2022 Mar; 27(2):e135-e141. PubMed ID: 35218642
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
8. Frequency of circulating CD14
Song Y; Zhou Q; Zhu H; Jing Y; Zhang X; Yang Y; Hu Q; Huang X; Ni Y
J Oral Pathol Med; 2018 Nov; 47(10):923-929. PubMed ID: 29961993
[TBL] [Abstract][Full Text] [Related]
9. An inverse association of Helicobacter pylori infection with oral squamous cell carcinoma.
Meng X; Wang Q; He C; Chen M; Liu J; Liu W; Yuan Y
J Oral Pathol Med; 2016 Jan; 45(1):17-22. PubMed ID: 25899621
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-23 receptor defines T helper 1-like regulatory T cells in oral squamous cell carcinoma.
Li W; An N; Wang M; Liu X; Mei Z
Immun Inflamm Dis; 2022 Dec; 10(12):e746. PubMed ID: 36444617
[TBL] [Abstract][Full Text] [Related]
11. Genetic Cross-Talk between Oral Squamous Cell Carcinoma and Type 2 Diabetes: The Potential Role of Immunity.
Fan Y; Zhang J; Shi J; Chen L; Long J; Zhang S; Liu S
Dis Markers; 2022; 2022():6389906. PubMed ID: 35634436
[TBL] [Abstract][Full Text] [Related]
12. Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma.
Chen X; Liu Q; Chen Y; Wang L; Yang R; Zhang W; Pan X; Zhang S; Chen C; Wu T; Xia J; Cheng B; Chen X; Ren X
Mol Metab; 2022 Nov; 65():101600. PubMed ID: 36113774
[TBL] [Abstract][Full Text] [Related]
13. Expansion of PMN-myeloid derived suppressor cells and their clinical relevance in patients with oral squamous cell carcinoma.
Zhong LM; Liu ZG; Zhou X; Song SH; Weng GY; Wen Y; Liu FB; Cao DL; Liu YF
Oral Oncol; 2019 Aug; 95():157-163. PubMed ID: 31345384
[TBL] [Abstract][Full Text] [Related]
14. Assessment of serum synuclein-γ and squamous cell carcinoma antigen as diagnostic biomarkers in patients with oral squamous cell carcinoma and oral potentially malignant disorders.
Chen L; Luo T; Yang J; Wang K; Liu S; Wei Y; Liu H; Xu J; Zheng J; Zeng Y
J Oral Pathol Med; 2021 Feb; 50(2):165-174. PubMed ID: 33064859
[TBL] [Abstract][Full Text] [Related]
15. The expression and role of tubulin polymerization-promoting protein 3 in oral squamous cell carcinoma.
Xiao T; Lin F; Zhou J; Tang Z
Arch Oral Biol; 2022 Nov; 143():105519. PubMed ID: 36058091
[TBL] [Abstract][Full Text] [Related]
16. Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease.
Krishnan R; Thayalan DK; Padmanaban R; Ramadas R; Annasamy RK; Anandan N
Asian Pac J Cancer Prev; 2014; 15(17):7141-8. PubMed ID: 25227804
[TBL] [Abstract][Full Text] [Related]
17. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Kang Y; Zhang Y; Sun Y
Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
[TBL] [Abstract][Full Text] [Related]
18. The balance of serum IL-18/IL-37 levels is disrupted during the development of oral squamous cell carcinoma.
Ding L; Zhao X; Zhu N; Zhao M; Hu Q; Ni Y
Surg Oncol; 2020 Mar; 32():99-107. PubMed ID: 31983439
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of chemokine (C-X-C motif) ligand 9 (CXCL9) are associated with tumor progression and treatment outcome in patients with oral cavity squamous cell carcinoma.
Chang KP; Wu CC; Fang KH; Tsai CY; Chang YL; Liu SC; Kao HK
Oral Oncol; 2013 Aug; 49(8):802-7. PubMed ID: 23769451
[TBL] [Abstract][Full Text] [Related]
20. Salivary Immunosuppressive Cytokines IL-10 and IL-13 Are Significantly Elevated in Oral Squamous Cell Carcinoma Patients.
Aziz S; Ahmed SS; Ali A; Khan FA; Zulfiqar G; Iqbal J; Khan AA; Shoaib M
Cancer Invest; 2015; 33(7):318-28. PubMed ID: 26046681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
